I
Interior Dermatology Centre | Kelowna, Canada
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Rocatinlimab
Brivekimig
Ustekinumab
Deucravacitinib
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 5 total trials
This is a Phase 2b, global, multicenter, sequential, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study in participants...
Enrolling
Hidradenitis Suppurativa
Drug: Brivekimig
Drug: Placebo
A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis
Enrolling
Plaque Psoriasis
Drug: Ustekinumab
Drug: Deucravacitinib
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems